We are live on ! Find out more
FBB

Fulton Breakefield Broenniman Portfolio holdings

AUM $1.7B
1-Year Est. Return 23.97%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+23.97%
3 Year Est. Return
+68.05%
5 Year Est. Return
+78.87%
10 Year Est. Return
+273.12%
AUM
$424M
AUM Growth
-$33M
Cap. Flow
-$13.4M
Cap. Flow %
-3.17%
Top 10 Hldgs %
20.7%
Holding
128
New
6
Increased
42
Reduced
71
Closed
9

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$4.41M
2
AAPL icon
Apple
AAPL
+$2.48M
3
SHPG
Shire pic
SHPG
+$2.45M
4
UNH icon
UnitedHealth
UNH
+$2.4M
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 14.19%
2 Consumer Discretionary 11.98%
3 Consumer Staples 11.77%
4 Technology 9.85%
5 Financials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERN
26
DELISTED
Cerner Corp
CERN
$6.09M 1.44%
101,649
+30,800
+43% +$2.01M
UL icon
27
Unilever
UL
$137B
$5.92M 1.4%
129,024
+1,533
+1% +$73.3K
ICF icon
28
iShares Select U.S. REIT ETF
ICF
$2.08B
$5.8M 1.37%
125,268
-1,132
-0.9% -$52.7K
BAC icon
29
Bank of America
BAC
$439B
$5.76M 1.36%
369,736
-10,610
-3% -$179K
MCD icon
30
McDonald's
MCD
$190B
$5.75M 1.35%
58,308
-88
-0.2% -$8.57K
TNL icon
31
Travel + Leisure Co
TNL
$4.76B
$5.59M 1.32%
172,161
-640
-0.4% -$23K
SHPG
32
DELISTED
Shire pic
SHPG
$5.56M 1.31%
27,084
+10,292
+61% +$2.45M
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
$5.36M 1.26%
34,290
+8,783
+34% +$1.6M
RTX icon
34
RTX Corp
RTX
$290B
$5.35M 1.26%
95,542
+251
+0.3% +$15.5K
AMGN icon
35
Amgen
AMGN
$205B
$5.34M 1.26%
38,636
-4,403
-10% -$694K
INTC icon
36
Intel
INTC
$491B
$5.26M 1.24%
174,430
-4,297
-2% -$124K
COP icon
37
ConocoPhillips
COP
$142B
$5.1M 1.2%
106,376
-3,371
-3% -$172K
XEL icon
38
Xcel Energy
XEL
$47.8B
$5.02M 1.18%
141,646
-451
-0.3% -$15.3K
DD
39
DELISTED
Du Pont De Nemours E I
DD
$4.99M 1.18%
103,506
-7,905
-7% -$422K
MCHP icon
40
Microchip Technology
MCHP
$42.8B
$4.95M 1.17%
229,638
-7,910
-3% -$171K
CVX icon
41
Chevron
CVX
$372B
$4.74M 1.12%
60,097
+783
+1% +$65.9K
NEE icon
42
NextEra Energy
NEE
$179B
$4.46M 1.05%
183,012
-12,336
-6% -$314K
DOV icon
43
Dover
DOV
$27.5B
$4.4M 1.04%
95,192
-1,454
-2% -$73.6K
BMY icon
44
Bristol-Myers Squibb
BMY
$132B
$4.32M 1.02%
72,978
-85,440
-54% -$5.42M
YUM icon
45
Yum! Brands
YUM
$40.5B
$4.26M 1%
74,083
-38,392
-34% -$2.32M
GPC icon
46
Genuine Parts
GPC
$17.8B
$4.24M 1%
51,129
+611
+1% +$52.6K
DOC icon
47
Healthpeak Properties
DOC
$14.7B
$3.96M 0.93%
116,679
+2,602
+2% +$90K
T icon
48
AT&T
T
$159B
$3.95M 0.93%
160,354
-16,001
-9% -$408K
CSCO icon
49
Cisco
CSCO
$476B
$3.91M 0.92%
148,969
+426
+0.3% +$11.5K
MCK icon
50
McKesson
MCK
$96.5B
$3.85M 0.91%
+20,825
New +$4.41M

Similar funds

Fulton Breakefield Broenniman's Q3 2015 Portfolio in Review

As of Q3 2015, Fulton Breakefield Broenniman held 128 positions worth $424M, down 7.2% from $457M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Fulton Breakefield Broenniman withdrew a net $13.4M in Q3 2015, closing 9 positions and reducing 71 holdings. Its most notable exit was Southern Company, an estimated $4.13M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Fulton Breakefield Broenniman opened a new position in McKesson worth $3.85M.

  • Fulton Breakefield Broenniman's largest Q3 2015 buy was McKesson: 20,825 shares worth $3.85M.
  • Fulton Breakefield Broenniman added most to Apple in Q3 2015, an estimated $2.48M increase.
  • Fulton Breakefield Broenniman's biggest Q3 2015 reduction was Marriott International, cutting an estimated $5.56M.
  • Fulton Breakefield Broenniman fully exited Southern Company in Q3 2015, selling an estimated $4.13M.
  • Fulton Breakefield Broenniman's ten largest holdings make up 21% of its $424M portfolio in Q3 2015.
  • Fulton Breakefield Broenniman opened 6 new positions and closed 9 in Q3 2015.
  • Fulton Breakefield Broenniman's portfolio value fell 7.2% quarter-over-quarter to $424M.

Based on Fulton Breakefield Broenniman's 13F filing for Q3 2015, filed 9 Nov 2015.